AGOURA HILLS, Calif.,
June 17, 2013 /PRNewswire/ -- The
Biozoom (OTC QB: BIZM) scanner is the world's first portable, hand
held device for the non-invasive transdermal analysis of
antioxidants and other biomarkers in the human body. It replaces
expensive, time consuming and invasive blood tests. At the a click
of a button, the Biozoom scanner reflects a beam of light off the
skin—using state-of-the-art optics developed with Carl
Zeiss—and measures the reflection. Using the scanner, researchers
from Charite Berlin one of
Europe's largest and most
respected university hospitals--joined researchers from the
University of Rostock to investigate a pressing health issue facing
the developed world: workplace stress. The Biozoom scanner was used
to measure antioxidants in the skin of midwives, a group selected
because of their nighttime shift work, a reported cause of stress
for many.
"The Biozoom scanner was ideal for this application," said Dr.
Jurgen Lademann, Director of
Charite's Center of Experimental and Applied Cutaneous Physiology,
"because it is portable, non-invasive and highly accurate,
returning results instantly. Using it, we have been able to
investigate the changing antioxidative status of human skin more
easily."
The concentration of antioxidants in human skin has been
shown to be linked to an individual's nutritional habits, as
well as by stressors such as shift work. Because midwives'
schedules are unpredictable and often require midnight shifts, the
workers' circadian rhythms and melatonin secretion are disturbed.
According to Charite, this type of schedule is associated with
insomnia, gastrointestinal disorders and a 40% higher risk of
developing coronary heart diseases.
Seven midwives' took part in the study. The results showed a
correlation between stress intensity and a decline in the midwives'
antioxidative status, suggesting that antioxidative status may be
adversely affected by shift work.
"For Biozoom, this study shows a centrally important benefit of
the scanner," said Hardy Hoheisel,
Biozoom's Chief Executive Officer. "While most of us recognize
that stress management is a key factor in improving
physical and emotional wellness, there have been few
commercially available ways to measure the effects of stress on the
body before it causes illness. The Biozoom scanner shows that
impact, making the antioxidative consequences of stress measurable
and giving people the information and reinforcement they need to
make positive lifestyle changes."
About Biozoom
Biozoom is an innovative technology development company,
specializing in the commercialization of our advances in mobile
spectroscopy. Our intellectual property portfolio and ongoing
research are positioned to apply Biozoom's technology breakthroughs
to a wide range of markets. Our first consumer product, the Biozoom
scanner, gives people the feedback they need to manage their
health, wellness and fitness on demand. Tested in leading
health institutions, our scanner is the first of its
kind—a handheld, transdermal device for measuring biomarkers,
including antioxidant levels, at the click of a button. Scan
results—and customized wellness coaching based on those
biomarkers—are sent instantly to a smartphone or online
account. The scanner will enable leaders in the health and
wellness industry to create new levels of customer loyalty and
revenues as a result. For more information, visit
www.biozoom.net.
About Charite Berlin
The Charite is one of the largest university hospitals
in Europe. Here, 3800 doctors and
scientists heal, do research and teach at the top international
level. More than half of the German Nobel Prize winners in
medicine and physiology come from the Charite, among them
Emil von Behring, Robert Koch and Paul
Ehrlich. The Charite also has an international
reputation for excellence in training. It extends over four
campuses with more than 100 clinics and institutes bundled under 17
Charite Centers. With 13,000 employees,
the Charite generates about 1.2
billion euros in sales per year and is one of the largest
employers in Berlin. In 2010,
the Charite could look back and joyously celebrated its
300-year anniversary.
About Rostock University
With its 200,000 inhabitants, Rostock is characterized
scientifically, economically and culturally by 15,000 students and
a work force of 5,000 in the university and university clinic.
External funding raised for research rose between 2005 and 2010 by
83% and currently stands above 47 million
Euros per year. The University of Rostock is among the ten
most founder-friendly higher education establishments in
Germany. The regional economy has
benefitted from the over 800 start-up companies launched from the
university since 1991.
Disclaimer
This press release contains "forward-looking statements".
Statements in this press release which are not purely historical
are forward-looking statements and include any statements regarding
beliefs, plans, expectations or intentions regarding the future,
and specifically references to future potential purchase orders and
re-orders from consumers and distributors. The reader can identify
these forward-looking statements by forward-looking words such as
"may," "will," "expect," "potential," "anticipate," "forecast,"
"believe," "estimate," "project," "plan," "continue" or similar
words. The reader should read statements that contain these words
carefully because they discuss future expectations, contain
projections of future results of operations or of financial
condition, or state other forward-looking information.
Forward-looking statements include, but are not limited to,
statements regarding potential products, customers, revenues,
expansion efforts, and future plans and objectives of Biozoom, Inc.
("Biozoom"). The risk factors listed in our disclosure documents
and the cautionary language therein provide examples of risks,
uncertainties and events that may cause actual results to differ
materially from the expectations and projections described by
Biozoom in its forward-looking statements. Actual results relating
to, among other things, product launch, sales, customer acceptance
and market share could differ materially from those currently
anticipated in such statements. Factors affecting forward-looking
statements include: consumer preferences, competition from more
established brands, ability to develop market share; changes in the
operating costs; changes in economic conditions, foreign exchange
and other financial markets; changes of the interest rates on
borrowings; changes in the investments levels; litigation;
legislation; environmental, judicial, regulatory, political and
competitive developments in areas in which Biozoom operates;
technological, mechanical and operational difficulties encountered
in connection with Biozoom's development activities; and labor
relation matters and costs. The reader should refer to the risk
disclosures set out in the periodic reports and other disclosure
documents filed by Biozoom from time to time with the Securities
and Exchange Commission and other regulatory authorities.
SOURCE Biozoom